ArticleInternational journal of molecular sciences2019

Improved Anticancer Effect of Recombinant Protein izTRAIL Combined with Sorafenib and Peptide iRGD.

Roman Fadeev et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.